KMB

Business Context and Reporting Period

Company: Kimberly-Clark Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2004
Business Overview: The Corporation operates three global segments: Personal Care (diapers, feminine care), Consumer Tissue (facial/bathroom tissue, paper towels), and Business-to-Business (health care products, professional tissue). The company is executing a strategic plan focused on brand building, cost reductions, and capital effectiveness.

Key Financial Metrics

Note: Total Debt calculated as Debt payable within one year ($502.5M) plus Long-Term Debt ($2,772.9M) as of June 30, 2004. Prior year debt figures derived from Dec 31, 2003 balance sheet ($864.3M + $2,733.7M).

Material Changes vs. Prior Period

• Revenue Growth: Q2 2004 net sales increased 6.5% year-over-year, driven by a 5% volume increase, favorable currency effects (3%), and product mix (1%). This was partially offset by a 2% decline in net selling prices due to competitive pressures.
• Profitability: Operating profit rose 6.2% in Q2 and 9.0% YTD. Growth was fueled by volume, cost savings (over $50M in Q2, $95M YTD), and favorable currency, which offset lower selling prices and higher fiber costs.
• Tax Rate: The effective income tax rate dropped significantly to 22.3% in Q2 2004 (from 29.1% in 2003) due to tax credits and deductions from a synthetic fuel partnership investment.
• Nonoperating Expense: Q2 2004 included a $38.7 million nonoperating expense (pretax loss) from the synthetic fuel partnership, compared to zero in the prior year.
• Segment Performance: Business-to-Business sales grew 12.1% in Q2, the strongest among segments, driven by global health care and K-C Professional volumes.

Guidance, Outlook, and Risks

• Earnings Guidance: Management reiterated full-year 2004 earnings guidance of $3.55 to $3.65 per share, expecting results toward the high end. Q3 2004 earnings are expected to be in the range of $0.88 to $0.90 per share.
• Capital Allocation: The company raised its full-year cost savings target to $175M–$200M (from $150M) and lowered capital spending guidance to $600M–$650M (from $750M). Consequently, the share repurchase target was increased by $400M to $1.4 billion.
• Spin-off: The board approved the spin-off of paper and Canadian pulp operations. A preliminary Form 10 was filed on July 7, 2004. Future guidance will be based on continuing operations post-spin-off.
• Operational Changes: The company is ceasing diaper manufacturing at its New Milford, Conn. facility to focus on tissue production, with estimated costs of $40 million (including $16M in Q2 and $25M in Q3).
• Risks and Contingencies:
  • Raw Materials: Higher fiber, oil, and energy costs are expected to impact margins, though price increases in consumer tissue are planned for Q3.
  • Environmental: Named as a potentially responsible party at various waste disposal sites, though management does not expect a material adverse effect.
  • Incidents: A fire occurred at the Thames Distribution Center in the U.K. on July 10, 2004; management does not anticipate a significant negative impact on operations or liquidity.

Investor Verification Checklist

• Synthetic Fuel Impact: Verify the sustainability of the lower effective tax rate (22.3%) driven by the synthetic fuel partnership, as this is a non-recurring or variable benefit.
• Price Realization: Monitor the success of planned price increases in the Consumer Tissue segment in Q3 to offset competitive pricing pressures and rising fiber costs.
• Spin-off Execution: Track the timeline and financial impact of the paper and Canadian pulp operations spin-off on future earnings guidance.
• Cost Savings: Confirm the achievement of the raised cost savings target ($175M–$200M) amidst higher raw material costs.
• Share Repurchases: Verify the execution of the increased $1.4 billion share repurchase program and its impact on diluted EPS.